Hydroxychloroquine in Outpatient Adults With COVID-19
Status:
Terminated
Trial end date:
2020-05-26
Target enrollment:
Participant gender:
Summary
Primary Objective:
To assess the effect of hydroxychloroquine versus placebo on nasopharyngeal SARS-CoV-2 viral
load in outpatient adults with COVID-19
Secondary Objectives:
- To assess the effect of hydroxychloroquine versus placebo on clinical signs and symptoms
and progression of disease in outpatient adults with COVID-19
- To assess the safety and tolerability of hydroxychloroquine in outpatient adults with
COVID-19